Choline acetyltransferase (ChAT) neurons are the cholinergic neurons of the central nervous system, defined by their expression of ChAT, the enzyme responsible for acetylcholine (ACh) synthesis. These neurons project widely throughout the brain and play essential roles in arousal, attention, learning, memory, and motor control. Their dysfunction is implicated in Alzheimer's disease, PD, and other neurological disorders.
ChAT neurons display distinct morphological features:
- Soma: Medium to large (15-30 μm), multipolar
- Dendrites: Extensive, with beaded terminals
- Axons: Widely projecting, varicose axons
- Terminals: Large dense-core vesicles and small synaptic vesicles
- Distribution: Basal forebrain, brainstem
| Marker |
Type |
Function |
| CHAT |
Enzyme |
Choline acetyltransferase |
| SLC5A7 |
Transporter |
Choline transporter (CHT1) |
| ACHE |
Enzyme |
Acetylcholinesterase |
| SLC18A3 |
Transporter |
VAChT (vesicular ACh transporter) |
| NGFR |
Receptor |
p75NTR (low-affinity NGF receptor) |
| NR4A2 |
Transcription |
Nurr1 |
- ACh synthesis: ChAT catalyzes acetyl-CoA + choline → ACh
- Vesicular packaging: VAChT packages ACh into vesicles
- Synaptic release: Calcium-dependent release
- Receptor activation: Nicotinic and muscarinic receptors
- Attention: Enhance signal-to-noise ratio
- Learning: Modulate synaptic plasticity
- Memory: Support consolidation
- Arousal: Maintain wakefulness
- Neuromuscular junction: Motor neuron control
- Autonomic ganglia: Autonomic regulation
- Reticular formation: Motor tone
Cholinergic neurons are severely affected:
- Early loss: Basal forebrain degeneration early
- ChAT decline: Enzyme activity reduces 60-90%
- ACh deficiency: Reduced synthesis
- Memory impairment: Correlates with cognitive decline
Cholinergic involvement:
- Pedunculopontine nucleus: Degeneration
- Cognitive deficits: Cholinergic contribution
- Gait freezing: PPN-cholinergic
- Treatment: Anticholinergics worsen
Motor neuron involvement:
- Motor neuron degeneration: Loss of α-motor neurons
- Neuromuscular junction: Synaptic dysfunction
- Respiratory failure: Diaphragm weakness
- Excitotoxicity: Glutamate-induced damage
Autoimmune attack:
- Anti-AChR antibodies: Block receptors
- NMJ dysfunction: Fatigue with use
- Treatment: AChE inhibitors
- Thymic involvement: Antibody production
- High ACh synthesis: Energy-intensive
- Choline transport: Rate-limiting step
- Mitochondrial dependence: For acetyl-CoA
- NGF dependence: Require nerve growth factor
- p75NTR signaling: Pro-apoptotic without NGF
- Retrograde transport: Vulnerable to disruption
- Motor neuron sensitivity: High glutamate receptors
- Calcium dysregulation: Massive influx
- SOD mutations: ALS models
| Region |
Projection |
Function |
| Basal forebrain |
Cortex, hippocampus |
Memory, attention |
| Pedunculopontine |
Thalamus |
Arousal, gait |
| Medial septal |
Hippocampus |
Memory |
| Spinal cord |
Motor neurons |
Movement |
- AChE inhibitors: Donepezil, rivastigmine
- NGF delivery: Experimental
- Cholinergic agonists: Muscarinic, nicotinic
- Cell therapy: Cholinergic neuron transplants